Ubc9 deficiency selectively impairs the functionality of common lymphoid progenitors (CLPs) during bone marrow hematopoiesis

Mohammed Abdelssalam Hassan Edrees; Jiahui Luo; Fei Sun; Faxi Wang; Long He; Tiantian Yue; Longmin Chen; Jing Zhang; Haifeng Zhou; Chunliang Yang; Ping Yang; Fei Xiong; Qilin Yu; Bao Ling Adam; Furong Liu; Jinxiu Li; Shu Zhang; Cong Yi Wang

doi:10.1016/j.molimm.2019.08.003

Ubc9 deficiency selectively impairs the functionality of common lymphoid progenitors (CLPs) during bone marrow hematopoiesis

Mohammed Abdelssalam Hassan Edrees, Jiahui Luo, Fei Sun, Faxi Wang, Long He, Tiantian Yue, Longmin Chen, Jing Zhang, Haifeng Zhou, Chunliang Yang, Ping Yang, Fei Xiong, Qilin Yu, Bao Ling Adam, Furong Liu, Jinxiu Li, Shu Zhang, Cong Yi Wang

Physiological and Technological Nursing

Research output: Contribution to journal › Article › peer-review

1 Scopus citations

Abstract

Hematopoietic development occurs in the bone marrow, and this process begins with hematopoietic stem cells (HSCs). Ubc9 is a unique E2-conjugating enzyme required for SUMOylation, an evolutionarily conserved post-translational modification system. We herein show that a conditional Ubc9 deletion in the hematopoietic system caused decreased thymus weight and reduced lymphocyte to myeloid cell ratio. Importantly, Ubc9 deletion in the hematopoietic system only selectively impaired the development of common lymphoid progenitors (CLPs) in the bone marrow and perturbed their potential to differentiate into lymphocytes, thereby decreasing the number of T/B cells in the periphery. Ubc9 was found to be required for CLP viability, and therefore, Ubc9 deficiency rendered CLPs to undergo apoptosis and attenuated their proliferation. Thus, Ubc9 plays a critical role in the regulation of CLP function during hematopoietic development in the bone marrow.

Original language	English (US)
Pages (from-to)	314-322
Number of pages	9
Journal	Molecular Immunology
Volume	114
DOIs	https://doi.org/10.1016/j.molimm.2019.08.003
State	Published - Oct 2019

Keywords

Common lymphoid progenitors
Hematopoietic development
Ubc9

ASJC Scopus subject areas

Immunology
Molecular Biology

Access to Document

10.1016/j.molimm.2019.08.003

Cite this

Edrees, M. A. H., Luo, J., Sun, F., Wang, F., He, L., Yue, T., Chen, L., Zhang, J., Zhou, H., Yang, C., Yang, P., Xiong, F., Yu, Q., Adam, B. L., Liu, F., Li, J., Zhang, S., & Wang, C. Y. (2019). Ubc9 deficiency selectively impairs the functionality of common lymphoid progenitors (CLPs) during bone marrow hematopoiesis. Molecular Immunology, 114, 314-322. https://doi.org/10.1016/j.molimm.2019.08.003

Ubc9 deficiency selectively impairs the functionality of common lymphoid progenitors (CLPs) during bone marrow hematopoiesis. / Edrees, Mohammed Abdelssalam Hassan; Luo, Jiahui; Sun, Fei; Wang, Faxi; He, Long; Yue, Tiantian; Chen, Longmin; Zhang, Jing; Zhou, Haifeng; Yang, Chunliang; Yang, Ping; Xiong, Fei; Yu, Qilin; Adam, Bao Ling; Liu, Furong; Li, Jinxiu; Zhang, Shu; Wang, Cong Yi.

In: Molecular Immunology, Vol. 114, 10.2019, p. 314-322.

Research output: Contribution to journal › Article › peer-review

Edrees, MAH, Luo, J, Sun, F, Wang, F, He, L, Yue, T, Chen, L, Zhang, J, Zhou, H, Yang, C, Yang, P, Xiong, F, Yu, Q, Adam, BL, Liu, F, Li, J, Zhang, S & Wang, CY 2019, 'Ubc9 deficiency selectively impairs the functionality of common lymphoid progenitors (CLPs) during bone marrow hematopoiesis', Molecular Immunology, vol. 114, pp. 314-322. https://doi.org/10.1016/j.molimm.2019.08.003

Edrees, Mohammed Abdelssalam Hassan ; Luo, Jiahui ; Sun, Fei ; Wang, Faxi ; He, Long ; Yue, Tiantian ; Chen, Longmin ; Zhang, Jing ; Zhou, Haifeng ; Yang, Chunliang ; Yang, Ping ; Xiong, Fei ; Yu, Qilin ; Adam, Bao Ling ; Liu, Furong ; Li, Jinxiu ; Zhang, Shu ; Wang, Cong Yi. / Ubc9 deficiency selectively impairs the functionality of common lymphoid progenitors (CLPs) during bone marrow hematopoiesis. In: Molecular Immunology. 2019 ; Vol. 114. pp. 314-322.

@article{5140b37a8e124d4287a3d53464645c7f,

title = "Ubc9 deficiency selectively impairs the functionality of common lymphoid progenitors (CLPs) during bone marrow hematopoiesis",

abstract = "Hematopoietic development occurs in the bone marrow, and this process begins with hematopoietic stem cells (HSCs). Ubc9 is a unique E2-conjugating enzyme required for SUMOylation, an evolutionarily conserved post-translational modification system. We herein show that a conditional Ubc9 deletion in the hematopoietic system caused decreased thymus weight and reduced lymphocyte to myeloid cell ratio. Importantly, Ubc9 deletion in the hematopoietic system only selectively impaired the development of common lymphoid progenitors (CLPs) in the bone marrow and perturbed their potential to differentiate into lymphocytes, thereby decreasing the number of T/B cells in the periphery. Ubc9 was found to be required for CLP viability, and therefore, Ubc9 deficiency rendered CLPs to undergo apoptosis and attenuated their proliferation. Thus, Ubc9 plays a critical role in the regulation of CLP function during hematopoietic development in the bone marrow.",

keywords = "Common lymphoid progenitors, Hematopoietic development, Ubc9",

author = "Edrees, {Mohammed Abdelssalam Hassan} and Jiahui Luo and Fei Sun and Faxi Wang and Long He and Tiantian Yue and Longmin Chen and Jing Zhang and Haifeng Zhou and Chunliang Yang and Ping Yang and Fei Xiong and Qilin Yu and Adam, {Bao Ling} and Furong Liu and Jinxiu Li and Shu Zhang and Wang, {Cong Yi}",

note = "Funding Information: This study was supported by the National Natural Science Foundation of China (81530024, 9174920038, 81471046, 81770823 and 81670929), the Ministry of Science and Technology (2016YFC1305002 and 2017YFC1309603), NHC Drug Discovery Program (2017ZX09304022-07), the Department of Science and Technology of Hubei State (2017ACA096), the Integrated Innovative Team for Major Human Disease Programs of Tongji Medical College, Huazhong University of Science and Technology, and the Innovative Funding for Translational Research from Tongji Hospital. Funding Information: This study was supported by the National Natural Science Foundation of China ( 81530024 , 9174920038 , 81471046 , 81770823 and 81670929 ), the Ministry of Science and Technology ( 2016YFC1305002 and 2017YFC1309603 ), NHC Drug Discovery Program ( 2017ZX09304022-07 ), the Department of Science and Technology of Hubei State ( 2017ACA096 ), the Integrated Innovative Team for Major Human Disease Programs of Tongji Medical College, Huazhong University of Science and Technology, and the Innovative Funding for Translational Research from Tongji Hospital. Publisher Copyright: {\textcopyright} 2019 Elsevier Ltd",

year = "2019",

month = oct,

doi = "10.1016/j.molimm.2019.08.003",

language = "English (US)",

volume = "114",

pages = "314--322",

journal = "Immunochemistry",

issn = "0161-5890",

publisher = "Elsevier Limited",

}

TY - JOUR

T1 - Ubc9 deficiency selectively impairs the functionality of common lymphoid progenitors (CLPs) during bone marrow hematopoiesis

AU - Edrees, Mohammed Abdelssalam Hassan

AU - Luo, Jiahui

AU - Sun, Fei

AU - Wang, Faxi

AU - He, Long

AU - Yue, Tiantian

AU - Chen, Longmin

AU - Zhang, Jing

AU - Zhou, Haifeng

AU - Yang, Chunliang

AU - Yang, Ping

AU - Xiong, Fei

AU - Yu, Qilin

AU - Adam, Bao Ling

AU - Liu, Furong

AU - Li, Jinxiu

AU - Zhang, Shu

AU - Wang, Cong Yi

N1 - Funding Information: This study was supported by the National Natural Science Foundation of China (81530024, 9174920038, 81471046, 81770823 and 81670929), the Ministry of Science and Technology (2016YFC1305002 and 2017YFC1309603), NHC Drug Discovery Program (2017ZX09304022-07), the Department of Science and Technology of Hubei State (2017ACA096), the Integrated Innovative Team for Major Human Disease Programs of Tongji Medical College, Huazhong University of Science and Technology, and the Innovative Funding for Translational Research from Tongji Hospital. Funding Information: This study was supported by the National Natural Science Foundation of China ( 81530024 , 9174920038 , 81471046 , 81770823 and 81670929 ), the Ministry of Science and Technology ( 2016YFC1305002 and 2017YFC1309603 ), NHC Drug Discovery Program ( 2017ZX09304022-07 ), the Department of Science and Technology of Hubei State ( 2017ACA096 ), the Integrated Innovative Team for Major Human Disease Programs of Tongji Medical College, Huazhong University of Science and Technology, and the Innovative Funding for Translational Research from Tongji Hospital. Publisher Copyright: © 2019 Elsevier Ltd

PY - 2019/10

Y1 - 2019/10

N2 - Hematopoietic development occurs in the bone marrow, and this process begins with hematopoietic stem cells (HSCs). Ubc9 is a unique E2-conjugating enzyme required for SUMOylation, an evolutionarily conserved post-translational modification system. We herein show that a conditional Ubc9 deletion in the hematopoietic system caused decreased thymus weight and reduced lymphocyte to myeloid cell ratio. Importantly, Ubc9 deletion in the hematopoietic system only selectively impaired the development of common lymphoid progenitors (CLPs) in the bone marrow and perturbed their potential to differentiate into lymphocytes, thereby decreasing the number of T/B cells in the periphery. Ubc9 was found to be required for CLP viability, and therefore, Ubc9 deficiency rendered CLPs to undergo apoptosis and attenuated their proliferation. Thus, Ubc9 plays a critical role in the regulation of CLP function during hematopoietic development in the bone marrow.

AB - Hematopoietic development occurs in the bone marrow, and this process begins with hematopoietic stem cells (HSCs). Ubc9 is a unique E2-conjugating enzyme required for SUMOylation, an evolutionarily conserved post-translational modification system. We herein show that a conditional Ubc9 deletion in the hematopoietic system caused decreased thymus weight and reduced lymphocyte to myeloid cell ratio. Importantly, Ubc9 deletion in the hematopoietic system only selectively impaired the development of common lymphoid progenitors (CLPs) in the bone marrow and perturbed their potential to differentiate into lymphocytes, thereby decreasing the number of T/B cells in the periphery. Ubc9 was found to be required for CLP viability, and therefore, Ubc9 deficiency rendered CLPs to undergo apoptosis and attenuated their proliferation. Thus, Ubc9 plays a critical role in the regulation of CLP function during hematopoietic development in the bone marrow.

KW - Common lymphoid progenitors

KW - Hematopoietic development

KW - Ubc9

UR - http://www.scopus.com/inward/record.url?scp=85070871779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070871779&partnerID=8YFLogxK

U2 - 10.1016/j.molimm.2019.08.003

DO - 10.1016/j.molimm.2019.08.003

M3 - Article

C2 - 31442915

AN - SCOPUS:85070871779

VL - 114

SP - 314

EP - 322

JO - Immunochemistry

JF - Immunochemistry

SN - 0161-5890

ER -

Ubc9 deficiency selectively impairs the functionality of common lymphoid progenitors (CLPs) during bone marrow hematopoiesis

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this